WebDec 2, 2024 · BioDiem Ltd (BDM1) floated on the Australian Securities Exchange (ASX) on Wednesday, 28 January 2004. BDM1's current share price of is a -$1.25 or 100% discount to its original offer price of $1.25. WebCompany profile page for Biodiem Ltd including stock price, company news, press releases, executives, board members, and contact information
Biodiem Def Share Price - BDMN ADVFN
WebThe trial investigated the tolerability and immunogenicity of escalating single doses of SCH 900795 [LAIV; BioDiem], an intranasal, live attenuated influenza A phase 1 trial of escalating doses of LAIV (SCH 900795) seasonal vaccine in healthy adults. ... Price : $35 * Buy Profile. Adis is an information provider. ... WebJan 4, 2024 · Download Share Price History for Biodiem Ltd [ASX,BDM] in a range of formats. ASX, BDM End of Day and Historical Share Prices [Biodiem Ltd] The worlds #1 website for end of day & historical stock data software update mbux
BioDiem Ltd. Reports Continued Progress in Development of …
WebMar 29, 2024 · Griffith University’s Industry Fund collaborates in BDM-I screening. April. 30/04/2014. Completion of Non-renounceable Entitlement Offer and Issue of Entitlement and Shortfall Shares. BDM-I antimicrobial – mechanism of action investigation. 23/04/2014. Non-Renounceable Entitlement Offer – Closure, Acceptances and Shortfall. 10/04/2014. WebOct 18, 2012 · Melbourne, 18 October 2012: Australian infectious disease therapy and vaccine development company BioDiem Ltd (ASX: BDM) announced today that it continues to make solid progress on its antimicrobial program with advancing preclinical data, new partnerships in negotiation, and a number of new key patents strengthening BioDiem’s … http://www.biodiem.com/wp-content/uploads/2024/09/21-09-22-BioDiem_OPAL-Update-and-EOFY-information.pdf software update metz blue